Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’

P. Jain, J. Gutierrez Bugarin, A. Guha, C. Jain, N. Patil, T. Shen, I. Stanevich, V. Nikore, K. Margolin, M. Ernstoff, V. Velcheti, J. Barnholtz-Sloan, A. Dowlati

Research output: Contribution to journalArticlepeer-review

Original languageUndefined
JournalESMO Open
DOIs
StatePublished - Dec 2021

Cite this